AMPK signaling: Got food?

A team of scientists at the Salk Institute for Biological Studies think they know how many—if not most—living organisms answer this question. They recently showed that when food supplies dwindle, mammals, fruitflies, or frogs probably activate the same ancient cell signaling pathway in order to conserve energy.

In a study published in the April 25, 2008 issue of Molecular Cell, investigators led by Reuben Shaw, Ph.D., assistant professor in the Molecular and Cell Biology Laboratory of the Dulbecco Center for Cancer Research, report that when mammalian cells sense that glucose and other nutrients are running short, they muffle a cellular protein called raptor, causing cells to slow their growth.

Not only do these studies reveal survival strategies likely common to complex and simple organisms alike, but they suggest an extremely intriguing link between cancer and diabetes.

“This paper provides the first direct biochemical explanation for how cell growth is inhibited under conditions when nutrients are low,” reports Shaw. “This very simple bio-circuit is literally the bare bones signal that most organisms use to say, ‘We’ve got food!’ ”

Researchers knew that when this circuit broke down, cells facing starvation simply continued to divide—oblivious to hard times and spending energy currency like a frenzied credit card shopper—until the cellular cash ran out and cells died. What Shaw wondered was whether all the circuit components had been identified.

Using mouse and human cells, Shaw and colleagues observed that when cells are kept hungry in a culture dish, a watchdog enzyme called AMPK jumps into action and attaches a chemical phosphate group to a target protein named raptor. As a result, raptor, whose job is to cradle a growth-promoting protein called mTOR, is disabled, inactivating mTOR and halting cell division. Cells then safely switch into energy conservation mode until plentiful times return.

Previously, Shaw and others had shown that although AMPK performs a critical growth-slowing function, it takes its orders from a biochemical big boss, the protein LKB1. LKB1 is a so-called tumor-suppressor, meaning that its loss correlates with formation of benign growths, called hamartomas, and some types of malignant lung and colon cancer. Once growth-regulating LKB1 was out of the picture, many of these tumors showed very high levels of unregulated mTOR activity.

That’s where Shaw’s latest investigations began. “We were trying to understand how mutation of the tumor suppressor LKB1 leads to colon cancer or sporadic lung cancer,” he says. “I had shown that LKB1 turns AMPK on, so the next question was, what does that do" If it regulated cancer, there had to be components of the pathway that regulated cell growth that no one had discovered.”

A collaborator, Benjamin Turk, Ph.D., of Yale University School of Medicine, helped Shaw identify that component. AMPK is a kinase, meaning that it adds phosphate groups—which sometimes activate and other times inhibit—to target proteins. Using Turk’s data, Shaw combed through collections of protein fragments biochemically phosphorylated by AMPK and fished out one corresponding to a novel candidate—raptor. Remarkably that tiny part of raptor protein looked similar in raptor proteins expressed in organisms ranging from slime molds to humans.

With raptor as the prime suspect, lead author and graduate student Dana Gwinn and other members of the Shaw lab undertook extensive biochemical studies to demonstrate that AMPK indeed directly phosphorylated raptor in response to energy stress, that mTOR activity then decreased, and that of all this kept starving cells from dividing until they dropped.

The study provides stunning insight into Mother Nature’s reluctance to tinker with strategies that meet organisms’ most basic needs. “Simply the most rudimentary information that any cell needs is to know whether there is food around—that’s what AMPK senses. If there is not, you need to turn off factors that make cells grow,” explains Shaw, specifically to the growth-promoting team of raptor and mTOR.

And as if solving evolutionary puzzles and dissecting tumor suppressor pathways isn’t enough, Shaw’s work overall hints at an even more profound clinical association: the widely used type 2 diabetes drug metformin activates AMPK, suggesting that the LKB1/AMPK pathway is a molecular link between diabetes and cancer. “This circuit could in part explain the increased cancer risk seen in type 2 diabetic patients,” says Shaw, noting many are predisposed to breast, prostate or colon cancer.

Could mutations in components of the LKB1/AMPK pathway underlie both pathologies" And if so, could drugs that effectively antagonize diabetes also antagonize tumor growth"

Those questions are next on Shaw’s agenda. “Not only will we continue to dissect this pathway biochemically, but we will more directly test whether we can treat certain types of tumors in mouse models with diabetes drugs,” Shaw says.

Also contributing to this study from the Shaw lab were postdoctoral fellows David Shackelford, Ph.D., and Annabelle Mery, Ph.D., graduate student Maria Mihaylova, and research assistants Debbie Vasquez and Daniel Egan.

Source: Salk Institute

Related stories:

Breakdown of kidney's ability to clean its own filters likely causes disease
The kidney actively cleans its most selective filter to keep it from clogging with blood proteins, scientists from Washington University School of Medicine in St. Louis reveal in a new study. Researchers showed that breakdown of this self-cleaning feature can make kidneys more vulnerable to dysfunction and disease.
Rogue bacteria involved in both heart disease and infertility
Outside the laboratory, Anthony Azenabor is outgoing and talkative, an extrovert who laughs heartily at his own jokes. But engrossed in his research, Azenabor is a shrewd and serious investigator who coaxes rogue bacteria to give up deadly secrets of how they cause several human illnesses.

Laser blasts viruses in blood
A father-son research team working from separate laboratory benches across the country has discovered a new use for lasers - zapping viruses out of blood. The technique, which holds promise for disinfecting blood for transfusions, uses a low-power laser beam with a pulse lasting just fractions of a second.
Engineering a new way to see dinosaurs
With the eye of an electrical engineer, Nels Peterson is hoping to bring a new, high-tech tool to the field excavation of dinosaurs, a labor of picks, shovels and brushes that has changed little over the past 100 years.
Lowering body temperature could aid standard stroke treatment
University of Cincinnati scientists have developed a model that could help physicians combine current clot-busting medication with below-normal body temperatures (hypothermia) to improve the treatment of ischemic stroke patients.
Protein's effects essential for kidney-to-bladder urine transfer
Tests of a protein's role in the immune system have revealed a surprising connection to a kidney problem that occurs in approximately one percent of all live births.
Rabbit eggs may be used for stem cells
Scientists in Scotland are planning to create animal-human embryos cloned from human skin cells and unfertilized rabbit eggs.
HIV infection stems from few viruses
A new study reveals the genetic identity of human immunodeficiency virus (HIV), the version responsible for sexual transmission, in unprecedented detail.

News discussion:

General Science news